EU Cracks Down on Credit Default Swaps Trading

Joe Goldman |

European antitrust officials have charged 13 major investment banks with colluding to keep derivatives trading, specifically credit default swaps, away from less profitable, more transparent public markets.

These credit default swaps (CDS) are a sensitive topic because they are widely known to have worsened the housing crash and deepened the global recession. They effectively act as an insurance policy against default on a loan, bond, mortgage, or other form of debt. They are also considered among the most lucrative trading derivatives in the world, and the EU has now charged the banks with illegally conspiring to control them.



According to the Wall Street Journal, the EU has charged Bank of America’s (BAC) Merill Lynch division, Barclays (BCS), Bear Stearns (now part of JPMorgan Chase), BNP Paribas (BNP), Citigroup (C), Credit Suisse (CS), Deutsche Bank (DB), Goldman Sachs (GS), HSBS Holdings (HBC), JPMorgan Chase (JPM), Morgan Stanley (MS), Royal Bank of Scotland (RBS), and UBS AG (UBS). The EU also charged the International Swaps and Derivatives Association, although the ISDA denied any wrongdoing. Meanwhile, none of the banks have issued public comments on the charges.

The EU stated on its website that the aforementioned investment banks “delayed the emergence of exchange trading of these financial products because they feared that it would reduce their revenues.  This, at least, is our preliminary conclusion.”

While the EU’s investigation remains ongoing, the banks don’t have much of a case. Investors and world governments are outraged that these dangerous CDS’s are still traded through nontransparent, over-the-counter exchanges, especially given the damage they caused during during 2008 and 2009.

The EU also warned, “If it is confirmed that banks collectively blocked exchanges from the CDS market, breaching the prohibition of anticompetitive agreements enshrined in the Treaty, it would be unacceptable and the Commission could decide to impose sanctions.”

The investment banks, however, didn’t fret Monday’s announcement, as most of their stocks traded up with the market. Citigroup rose 1.6 percent, JPMorgan Chase rose .4 percent, Morgan Stanley rose 1.4 percent, while almost all ten of the other accused banks traded positively as well.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
BCS Barclays PLC 10.65 -0.16 -1.48 2,190,310 Trade
C Citigroup Inc. 66.00 -0.36 -0.54 14,075,511 Trade
MS Morgan Stanley 46.59 0.08 0.17 9,021,263 Trade
JPM JP Morgan Chase 90.89 -0.31 -0.34 10,971,292 Trade
DB Deutsche Bank AG 18.22 -0.24 -1.30 2,562,218 Trade
GS The Goldman Sachs Group Inc. 220.18 -2.12 -0.95 3,446,620 Trade
BAC Bank of America Corporation 23.80 -0.14 -0.58 65,922,474 Trade
RBS Royal Bank of Scotland Group Plc New (The) ADS 6.49 -0.07 -1.07 839,965 Trade
UBS UBS Group AG Registered 17.66 -0.14 -0.79 1,147,889 Trade
PAYX Paychex Inc. 57.20 0.01 0.02 1,937,649 Trade

Comments

Emerging Growth

Radient Technologies Inc.

Radient Technologies Inc is engaged in research, development and commercialization of environmentally responsible technology for the extraction, isolation and purification of soluble products from a wide range of materials using…

Private Markets

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…

California Green Tree Development

California Green Tree Development LLC (CGTD) is a for-profit LLC that plans on using California’s booming market of legal cannabis products for medical purposes. As an unprecedented resource, Cannabis has…